$BMRN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOMARIN PHARMACEUTICAL INC. Get notifications about new insider transactions in BIOMARIN PHARMACEUTICAL INC for free.
Page: < prev 1 ... 30 31 32 33 34
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 14.34 | 12,500 | 179,188 | 10,000 | 22.5 K to 10 K (-55.56 %) |
Aug 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Buy | M | 4.00 | 12,500 | 50,000 | 22,500 | 10 K to 22.5 K (+125.00 %) |
Aug 01 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 14.50 | 1,500 | 21,750 | 30,881 | 29.4 K to 30.9 K (+5.11 %) |
Jul 14 2006 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | A | 14.93 | 30,000 | 447,900 | 140,000 | |
Jul 05 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 14.44 | 500 | 7,220 | 29,381 | 28.9 K to 29.4 K (+1.73 %) |
Jul 05 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 14.44 | 1,000 | 14,440 | 28,881 | 27.9 K to 28.9 K (+3.59 %) |
Jun 15 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 13.15 | 500 | 6,575 | 27,881 | 27.4 K to 27.9 K (+1.83 %) |
Jun 15 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 13.20 | 500 | 6,598 | 27,381 | 26.9 K to 27.4 K (+1.86 %) |
Jun 15 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 13.23 | 500 | 6,617 | 26,881 | 26.4 K to 26.9 K (+1.90 %) |
Jun 15 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 13.30 | 1,000 | 13,300 | 26,381 | 25.4 K to 26.4 K (+3.94 %) |
Jun 15 2006 | BMRN | BIOMARIN PHARMACEU ... | CRISTIANI FRANZ L | Director | Option Exercise | A | 13.25 | 30,000 | 397,500 | 135,000 | |
Jun 02 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 13.05 | 1,500 | 19,575 | 25,381 | 23.9 K to 25.4 K (+6.28 %) |
May 22 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 12.00 | 1,000 | 12,000 | 23,881 | 22.9 K to 23.9 K (+4.37 %) |
May 12 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 12.99 | 250,000 | 3,247,500 | 900,000 | |
May 12 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 12.99 | 162,500 | 2,110,875 | 650,000 | |
May 09 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 12.78 | 1,000 | 12,778 | 22,881 | 21.9 K to 22.9 K (+4.57 %) |
May 03 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 6.92 | 3,381 | 23,393 | 21,881 | 18.5 K to 21.9 K (+18.28 %) |
May 03 2006 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Grant | A | 3.43 | 4,202 | 14,430 | 33,776 | 29.6 K to 33.8 K (+14.21 %) |
May 03 2006 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Grant | A | 3.43 | 3,797 | 13,039 | 26,546 | 22.7 K to 26.5 K (+16.69 %) |
May 03 2006 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Grant | A | 6.92 | 959 | 6,635 | 959 | 0 to 959 |
May 03 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 12.56 | 500 | 6,280 | 18,500 | 18 K to 18.5 K (+2.78 %) |
May 03 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 12.55 | 500 | 6,275 | 18,000 | 17.5 K to 18 K (+2.86 %) |
May 03 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 12.65 | 500 | 6,325 | 17,500 | 17 K to 17.5 K (+2.94 %) |
Apr 05 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 13.33 | 300 | 3,999 | 17,000 | 16.7 K to 17 K (+1.80 %) |
Apr 05 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 13.35 | 1,200 | 16,020 | 16,700 | 15.5 K to 16.7 K (+7.74 %) |
Mar 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | M | 6.13 | 13,500 | 82,755 | 223,500 | |
Mar 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | M | 5.15 | 2,000 | 10,300 | 237,000 | |
Mar 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Sell | S | 13.25 | 13,500 | 178,875 | 0 | 13.5 K to 0 (-100.00 %) |
Mar 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Buy | M | 6.13 | 13,500 | 82,755 | 13,500 | 0 to 13.5 K |
Mar 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Sell | S | 13.25 | 2,000 | 26,500 | 0 | 2 K to 0 (-100.00 %) |
Mar 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Buy | M | 5.15 | 2,000 | 10,300 | 2,000 | 0 to 2 K |
Mar 01 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 12.96 | 500 | 6,480 | 15,500 | 15 K to 15.5 K (+3.33 %) |
Mar 01 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 13.00 | 500 | 6,500 | 15,000 | 14.5 K to 15 K (+3.45 %) |
Mar 01 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 13.02 | 500 | 6,510 | 14,500 | 14 K to 14.5 K (+3.57 %) |
Mar 17 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | M | 8.10 | 12,500 | 101,250 | 211,000 | |
Mar 17 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Sell | S | 14.85 | 12,500 | 185,625 | 0 | 12.5 K to 0 (-100.00 %) |
Mar 17 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Buy | M | 8.10 | 12,500 | 101,250 | 12,500 | 0 to 12.5 K |
Feb 27 2006 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Option Exercise | M | 7.00 | 11,500 | 80,500 | 194,135 | |
Feb 27 2006 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Sell | S | 12.64 | 11,500 | 145,360 | 3,309 | 14.8 K to 3.3 K (-77.66 %) |
Feb 27 2006 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Buy | M | 7.00 | 11,500 | 80,500 | 14,809 | 3.3 K to 14.8 K (+347.54 %) |
Feb 27 2006 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Buy | P | 13.00 | 1,900 | 24,700 | 3,500 | 1.6 K to 3.5 K (+118.75 %) |
Feb 27 2006 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Buy | P | 12.98 | 400 | 5,192 | 1,600 | 1.2 K to 1.6 K (+33.33 %) |
Feb 27 2006 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Buy | P | 12.97 | 1,200 | 15,564 | 1,200 | 0 to 1.2 K |
Feb 27 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | M | 5.15 | 1,000 | 5,150 | 239,000 | |
Feb 27 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Sell | S | 13.25 | 1,000 | 13,250 | 0 | 1,000 to 0 (-100.00 %) |
Feb 27 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Buy | M | 5.15 | 1,000 | 5,150 | 1,000 | 0 to 1,000 |
Feb 24 2006 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Option Exercise | M | 7.00 | 1,000 | 7,000 | 205,635 | |
Feb 24 2006 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Sell | S | 12.20 | 1,000 | 12,200 | 3,309 | 4.3 K to 3.3 K (-23.21 %) |
Feb 24 2006 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Buy | M | 7.00 | 1,000 | 7,000 | 4,309 | 3.3 K to 4.3 K (+30.22 %) |
Feb 03 2006 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | M | 4.00 | 10,000 | 40,000 | 397,894 | |
Feb 03 2006 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 11.55 | 10,000 | 115,473 | 10,000 | 20 K to 10 K (-50.00 %) |
Feb 03 2006 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Buy | M | 4.00 | 10,000 | 40,000 | 20,000 | 10 K to 20 K (+100.00 %) |
Feb 03 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 11.73 | 500 | 5,865 | 14,000 | 13.5 K to 14 K (+3.70 %) |
Feb 03 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 11.65 | 500 | 5,825 | 13,500 | 13 K to 13.5 K (+3.85 %) |
Feb 03 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 11.62 | 500 | 5,810 | 13,000 | 12.5 K to 13 K (+4.00 %) |
Jan 30 2006 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Option Exercise | M | 7.00 | 2,500 | 17,500 | 214,135 | |
Jan 30 2006 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Sell | S | 12.20 | 2,500 | 30,500 | 3,309 | 5.8 K to 3.3 K (-43.04 %) |
Jan 30 2006 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Buy | M | 7.00 | 2,500 | 17,500 | 5,809 | 3.3 K to 5.8 K (+75.55 %) |
Jan 30 2006 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Option Exercise | A | 11.15 | 30,000 | 334,500 | 90,000 | |
Jan 10 2006 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | SVP, Chief Medical ... | Option Exercise | A | 11.74 | 75,000 | 880,500 | 634,127 | |
Jan 10 2006 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | SVP, Chief Medical ... | Grant | A | 3.43 | 2,572 | 8,832 | 29,574 | 27 K to 29.6 K (+9.53 %) |
Jan 10 2006 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Commercial Ope ... | Option Exercise | A | 11.74 | 75,000 | 880,500 | 568,243 | |
Jan 10 2006 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Commercial Ope ... | Grant | A | 3.43 | 3,640 | 12,500 | 22,749 | 19.1 K to 22.7 K (+19.05 %) |
Jan 10 2006 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | A | 11.74 | 75,000 | 880,500 | 407,894 | |
Jan 10 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | A | 11.74 | 60,000 | 704,400 | 240,000 | |
Jan 10 2006 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Option Exercise | A | 11.74 | 75,000 | 880,500 | 200,000 | |
Jan 04 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 10.81 | 1,000 | 10,810 | 12,500 | 11.5 K to 12.5 K (+8.70 %) |
Jan 04 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 10.76 | 500 | 5,380 | 11,500 | 11 K to 11.5 K (+4.55 %) |
Dec 21 2005 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | A | 10.33 | 30,000 | 309,900 | 30,000 | |
Dec 13 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 10.21 | 500 | 5,104 | 11,000 | 10.5 K to 11 K (+4.76 %) |
Dec 13 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 10.21 | 500 | 5,104 | 10,500 | 10 K to 10.5 K (+5.00 %) |
Dec 06 2005 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Option Exercise | M | 5.33 | 7,500 | 39,975 | 209,135 | |
Dec 06 2005 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Sell | S | 10.70 | 7,500 | 80,261 | 3,309 | 10.8 K to 3.3 K (-69.39 %) |
Dec 02 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 10.05 | 200 | 2,010 | 10,000 | 9.8 K to 10 K (+2.04 %) |
Dec 02 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 9.97 | 500 | 4,985 | 9,800 | 9.3 K to 9.8 K (+5.38 %) |
Dec 02 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 9.92 | 300 | 2,976 | 9,300 | 9 K to 9.3 K (+3.33 %) |
Dec 02 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 9.89 | 500 | 4,945 | 9,000 | 8.5 K to 9 K (+5.88 %) |
Dec 02 2005 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Option Exercise | M | 4.00 | 5,571 | 22,284 | 422,671 | |
Dec 02 2005 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Sell | S | 10.00 | 10,571 | 105,710 | 295,176 | 305.7 K to 295.2 K (-3.46 %) |
Oct 05 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 8.51 | 1,500 | 12,765 | 6,000 | 4.5 K to 6 K (+33.33 %) |
Dec 02 2005 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Option Exercise | M | 5.33 | 22,500 | 119,925 | 216,635 | |
Dec 02 2005 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Option Exercise | A | 9.74 | 30,000 | 292,200 | 239,135 | |
Dec 02 2005 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Sell | S | 10.42 | 22,500 | 234,450 | 0 | 22.5 K to 0 (-100.00 %) |
Nov 23 2005 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | M | 4.00 | 30,000 | 120,000 | 332,894 | |
Nov 23 2005 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 10.00 | 30,000 | 300,000 | 10,000 | 40 K to 10 K (-75.00 %) |
Nov 23 2005 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Option Exercise | M | 4.00 | 3,311 | 13,244 | 428,242 | |
Nov 23 2005 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Option Exercise | M | 4.00 | 2,260 | 9,040 | 431,553 | |
Nov 23 2005 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Sell | S | 10.00 | 3,311 | 33,110 | 300,176 | 303.5 K to 300.2 K (-1.09 %) |
Nov 23 2005 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Sell | S | 10.00 | 2,260 | 22,600 | 300,176 | 302.4 K to 300.2 K (-0.75 %) |
Nov 23 2005 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Sell | S | 10.00 | 5,000 | 50,000 | 300,176 | 305.2 K to 300.2 K (-1.64 %) |
Nov 14 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 9.86 | 162,500 | 1,602,250 | 487,500 | |
Nov 01 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 8.38 | 500 | 4,190 | 8,500 | 8 K to 8.5 K (+6.25 %) |
Nov 01 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 8.36 | 1,000 | 8,360 | 8,000 | 7 K to 8 K (+14.29 %) |
Oct 12 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 7.00 | 500 | 3,500 | 6,500 | 6 K to 6.5 K (+8.33 %) |
Oct 06 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 8.00 | 500 | 4,000 | 6,500 | 6 K to 6.5 K (+8.33 %) |
Sep 02 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 8.58 | 4,500 | 38,588 | 4,500 | 0 to 4.5 K |
Aug 04 2005 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | SVP, Business Opera ... | Option Exercise | A | 8.05 | 20,000 | 161,000 | 559,127 | |
Jul 14 2005 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | A | 7.46 | 30,000 | 223,800 | 110,000 | |
Jul 06 2005 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 7.72 | 30,000 | 231,600 | 30,000 | |
Jul 05 2005 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Option Exercise | A | 7.16 | 125,000 | 895,000 | 125,000 | |
Jun 16 2005 | BMRN | BIOMARIN PHARMACEU ... | CRISTIANI FRANZ L | Director | Option Exercise | A | 6.50 | 30,000 | 195,000 | 105,000 | |
Jun 30 2005 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Option Exercise | A | 7.72 | 30,000 | 231,600 | 30,000 | |
May 13 2005 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 6.46 | 325,000 | 2,099,500 | 325,000 | |
May 09 2005 | BMRN | BIOMARIN PHARMACEU ... | DRAPEAU LOUIS | Chief Executive Off ... | Grant | A | 3.43 | 4,004 | 13,750 | 14,934 | 10.9 K to 14.9 K (+36.63 %) |
May 09 2005 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Grant | A | 3.43 | 616 | 2,115 | 19,109 | 18.5 K to 19.1 K (+3.33 %) |
May 09 2005 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | SVP, Business Opera ... | Grant | A | 3.43 | 1,968 | 6,758 | 27,002 | 25 K to 27 K (+7.86 %) |
Jan 31 2005 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Option Exercise | A | 5.92 | 30,000 | 177,600 | 60,000 | |
Jan 10 2005 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Option Exercise | A | 6.13 | 140,000 | 858,200 | 493,243 | |
Jan 10 2005 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | A | 6.13 | 60,000 | 367,800 | 180,000 | |
Jan 10 2005 | BMRN | BIOMARIN PHARMACEU ... | DRAPEAU LOUIS | Chief Executive Off ... | Option Exercise | A | 6.13 | 100,000 | 613,000 | 315,000 | |
Jan 10 2005 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | SVP, Business Opera ... | Option Exercise | A | 6.13 | 100,000 | 613,000 | 539,127 | |
Jan 10 2005 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Option Exercise | A | 6.13 | 60,000 | 367,800 | 433,813 | |
Jan 10 2005 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | A | 6.13 | 80,000 | 490,400 | 362,894 | |
Dec 06 2004 | BMRN | BIOMARIN PHARMACEU ... | LANDAU JEFFREY | SVP, Administration | Grant | A | 3.51 | 712 | 2,499 | 2,740 | 2 K to 2.7 K (+35.11 %) |
Dec 06 2004 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Grant | A | 3.51 | 3,562 | 12,504 | 18,493 | 14.9 K to 18.5 K (+23.86 %) |
Dec 06 2004 | BMRN | BIOMARIN PHARMACEU ... | DRAPEAU LOUIS | Chief Executive Off ... | Grant | A | 3.51 | 3,687 | 12,943 | 10,930 | 7.2 K to 10.9 K (+50.90 %) |
Dec 06 2004 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | SVP, Business Opera ... | Grant | A | 3.51 | 1,924 | 6,754 | 25,034 | 23.1 K to 25 K (+8.33 %) |
Dec 02 2004 | BMRN | BIOMARIN PHARMACEU ... | SAGER ERICH | Director | Option Exercise | A | 5.33 | 30,000 | 159,900 | 209,135 | |
Dec 02 2004 | BMRN | BIOMARIN PHARMACEU ... | WILLIAMS GWYNN | Director | Option Exercise | A | 5.33 | 30,000 | 159,900 | 135,000 | |
Aug 23 2004 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | A | 5.15 | 10,000 | 51,500 | 120,000 | |
Aug 20 2004 | BMRN | BIOMARIN PHARMACEU ... | DRAPEAU LOUIS | Chief Executive Off ... | Option Exercise | A | 5.15 | 25,000 | 128,750 | 215,000 | |
Jul 29 2004 | BMRN | BIOMARIN PHARMACEU ... | URQUHART JOHN | Director | Option Exercise | A | 5.57 | 30,000 | 167,100 | 60,000 | |
Jul 12 2004 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | A | 5.12 | 30,000 | 153,600 | 80,000 | |
Jun 15 2004 | BMRN | BIOMARIN PHARMACEU ... | CRISTIANI FRANZ L | Director | Option Exercise | A | 5.97 | 30,000 | 179,100 | 75,000 | |
Jun 04 2004 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Sell | S | 7.61 | 5,000 | 38,050 | 305,176 | 310.2 K to 305.2 K (-1.61 %) |
Jun 04 2004 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Sell | S | 7.66 | 5,000 | 38,325 | 310,176 | 315.2 K to 310.2 K (-1.59 %) |
May 11 2004 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Buy | P | 6.12 | 8,000 | 48,960 | 14,931 | 6.9 K to 14.9 K (+115.42 %) |
May 07 2004 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | SVP, Business Opera ... | Buy | P | 6.48 | 5,000 | 32,400 | 26,110 | 21.1 K to 26.1 K (+23.69 %) |
May 07 2004 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | SVP, Business Opera ... | Buy | P | 6.50 | 10,000 | 65,000 | 21,110 | 11.1 K to 21.1 K (+90.01 %) |
May 07 2004 | BMRN | BIOMARIN PHARMACEU ... | PRICE FREDRIC D | Chief Executive Off ... | Buy | P | 6.37 | 5,000 | 31,850 | 79,285 | 74.3 K to 79.3 K (+6.73 %) |
May 07 2004 | BMRN | BIOMARIN PHARMACEU ... | PRICE FREDRIC D | Chief Executive Off ... | Buy | P | 6.33 | 5,000 | 31,650 | 74,285 | 69.3 K to 74.3 K (+7.22 %) |
May 07 2004 | BMRN | BIOMARIN PHARMACEU ... | PRICE FREDRIC D | Chief Executive Off ... | Buy | P | 6.27 | 5,000 | 31,350 | 69,285 | 64.3 K to 69.3 K (+7.78 %) |
May 07 2004 | BMRN | BIOMARIN PHARMACEU ... | DRAPEAU LOUIS | CFO, VP, Finance & ... | Grant | A | 5.70 | 2,192 | 12,502 | 7,243 | 5.1 K to 7.2 K (+43.40 %) |
May 07 2004 | BMRN | BIOMARIN PHARMACEU ... | LANDAU JEFFREY | SVP, Administration | Grant | A | 5.10 | 491 | 2,504 | 2,028 | 1.5 K to 2 K (+31.95 %) |
May 07 2004 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Grant | A | 5.10 | 2,423 | 12,357 | 6,931 | 4.5 K to 6.9 K (+53.75 %) |
Apr 05 2004 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Option Exercise | M | 4.00 | 5,570 | 22,280 | 373,813 | |
Apr 05 2004 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Sell | S | 8.00 | 5,570 | 44,560 | 315,176 | 320.7 K to 315.2 K (-1.74 %) |
Apr 05 2004 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Buy | M | 4.00 | 5,570 | 22,280 | 320,746 | 315.2 K to 320.7 K (+1.77 %) |
Apr 02 2004 | BMRN | BIOMARIN PHARMACEU ... | STARR CHRISTOPHER M | SVP, Chief Scientif ... | Sell | S | 7.56 | 5,000 | 37,795 | 315,176 | 320.2 K to 315.2 K (-1.56 %) |
Jan 27 2004 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Option Exercise | A | 8.47 | 30,000 | 254,100 | 30,000 | |
Jul 28 2003 | BMRN | BIOMARIN PHARMACEU ... | URQUHART JOHN | Director | Option Exercise | A | 10.34 | 30,000 | 310,200 | 30,000 | |
Jul 29 2003 | BMRN | BIOMARIN PHARMACEU ... | WILLIAMS GWYNN | Director | Sell | S | 10.00 | 68,700 | 687,000 | 812,565 | 881.3 K to 812.6 K (-7.80 %) |